Back
Lantern Pharma Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
40
LTRN
Lantern Pharma
Last Price:
3.78
Seasonality Move:
0.23%
Sell
49
NBY
NovaBay Pharmaceuticals
Last Price:
0.70
Seasonality Move:
-22.66%
Sell
40
Lantern Pharma (LTRN)
is a Sell
Is Lantern Pharma a Buy, Sell or Hold?
- The current Lantern Pharma [LTRN] share price is $3.78. The Score for LTRN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- LTRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LTRN Stock Price Chart
What is Lantern Pharma's stock price today?
-
The Lantern Pharma share price today is $3.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LTRN is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.71
The current trend is relatively stagnant and NBY is experiencing slight buying pressure.
LTRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 45.39 | Sell |
Chaikin Money Flow: | -26488 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.57 - 4.23) | Sell |
Bollinger Bands (100): | (3.76 - 5.62) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 57.14 | Buy |
Chaikin Money Flow: | 63291 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.44 - 0.64) | Buy |
Bollinger Bands (100): | (0.44 - 3.24) | Sell |
LTRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.96 | Sell |
20-day SMA: | 3.79 | Sell |
50-day SMA: | 4.06 | Sell |
200-day SMA: | 5.09 | Sell |
8-day EMA: | 3.89 | Sell |
20-day EMA: | 3.91 | Sell |
50-day EMA: | 4.12 | Sell |
200-day EMA: | 4.77 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.67 | Buy |
20-day SMA: | 0.55 | Buy |
50-day SMA: | 0.69 | Buy |
200-day SMA: | 3.51 | Sell |
8-day EMA: | 0.67 | Buy |
20-day EMA: | 0.61 | Buy |
50-day EMA: | 0.9 | Sell |
200-day EMA: | 7.9 | Sell |
Lantern Pharma Earnings Growth & LTRN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.59 per share, and an increase next year of $0.24 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Lantern Pharma Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |